IntroductionModafinil, a wakefulness-promoting agent, has garnered significant attention in recent years, significantly among those in search of cognitive enhancement and increased productivity. Initially accredited by the U.S. Meals and Drug Administration (FDA) for the therapy of narcolepsy, shift work sleep disorder, and obstructive sleep apnea, its off-label use has
